AAAAAA

   
Results: 1-25 |
Results: 25
NEW HORMONAL BLOCKADE STRATEGIES IN CARDIOVASCULAR-DISEASE
Authors: JOHNSTON CI NAITOH M RISVANIS J FARINA N BURRELL LM
Citation: Ci. Johnston et al., NEW HORMONAL BLOCKADE STRATEGIES IN CARDIOVASCULAR-DISEASE, SC CARDIOVA, 32, 1998, pp. 61-66
LONG-TERM EFFECTS OF NONPEPTIDE VASOPRESSIN V-2 ANTAGONIST OPC-31260 IN HEART-FAILURE IN THE RAT
Authors: BURRELL LM PHILLIPS PA RISVANIS J CHAN RK ALDRED KL JOHNSTON CI
Citation: Lm. Burrell et al., LONG-TERM EFFECTS OF NONPEPTIDE VASOPRESSIN V-2 ANTAGONIST OPC-31260 IN HEART-FAILURE IN THE RAT, American journal of physiology. Heart and circulatory physiology, 44(1), 1998, pp. 176-182
MECHANISM OF PROGRESSION OF RENAL-DISEASE - CURRENT HEMODYNAMIC CONCEPTS
Authors: JOHNSTON CI RISVANIS J NAITOH M TIKKANEN I
Citation: Ci. Johnston et al., MECHANISM OF PROGRESSION OF RENAL-DISEASE - CURRENT HEMODYNAMIC CONCEPTS, Journal of hypertension, 16, 1998, pp. 3-7
VASOPRESSIN V1A AND V2 RECEPTOR MESSENGER-RNA IN DEOXYCORTICOSTERONE ACETATE SALT HYPERTENSION IN THE RAT
Authors: RISVANIS J JOHNSTON CI PHILLIPS PA BURRELL LM
Citation: J. Risvanis et al., VASOPRESSIN V1A AND V2 RECEPTOR MESSENGER-RNA IN DEOXYCORTICOSTERONE ACETATE SALT HYPERTENSION IN THE RAT, Clinical science, 94(5), 1998, pp. 517-523
CHRONIC VASOPRESSIN ANTAGONISM IN 2-KIDNEY, ONE-CLIP RENOVASCULAR HYPERTENSION
Authors: BURRELL LM RISVANIS J PHILLIPS PA NAITOH M JOHNSTON CI
Citation: Lm. Burrell et al., CHRONIC VASOPRESSIN ANTAGONISM IN 2-KIDNEY, ONE-CLIP RENOVASCULAR HYPERTENSION, Clinical and experimental hypertension, 19(5-6), 1997, pp. 981-991
PRECLINICAL PHARMACOLOGY OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS - UPDATE AND OUTSTANDING ISSUES
Authors: JOHNSTON CI RISVANIS J
Citation: Ci. Johnston et J. Risvanis, PRECLINICAL PHARMACOLOGY OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS - UPDATE AND OUTSTANDING ISSUES, American journal of hypertension, 10(12), 1997, pp. 306-310
MODULATION OF GENETIC-HYPERTENSION BY SHORT-TERM AVP V-1A OR V-2 RECEPTOR ANTAGONISM IN YOUNG SHR
Authors: NAITOH M BURRELL LM RISVANIS J ALDRED KL ROCKELL MD JOHNSTON CI PHILLIPS PA
Citation: M. Naitoh et al., MODULATION OF GENETIC-HYPERTENSION BY SHORT-TERM AVP V-1A OR V-2 RECEPTOR ANTAGONISM IN YOUNG SHR, American journal of physiology. Renal, fluid and electrolyte physiology, 41(2), 1997, pp. 229-234
INHIBITION OF NEUTRAL ENDOPEPTIDASE, THE DEGRADATIVE ENZYME FOR NATRIURETIC PEPTIDES, IN RAT-KIDNEY AFTER ORAL SCH-42495
Authors: BURRELL LM FARINA N RISVANIS J WOOLLARD D CASELY D JOHNSTON CI
Citation: Lm. Burrell et al., INHIBITION OF NEUTRAL ENDOPEPTIDASE, THE DEGRADATIVE ENZYME FOR NATRIURETIC PEPTIDES, IN RAT-KIDNEY AFTER ORAL SCH-42495, Clinical science, 93(1), 1997, pp. 43-50
CHARACTERIZATION OF A NONPEPTIDE ORALLY-ACTIVE ENDOTHELIN (ET(A) AND ET(B)) RECEPTOR ANTAGONIST
Authors: RISVANIS J PHILLIPS PA ALDRED K BURRELL LM
Citation: J. Risvanis et al., CHARACTERIZATION OF A NONPEPTIDE ORALLY-ACTIVE ENDOTHELIN (ET(A) AND ET(B)) RECEPTOR ANTAGONIST, Kidney international, 50(4), 1996, pp. 1407-1408
IN-VIVO EFFECT OF CHRONIC VASOPRESSIN V1 AND V2 RECEPTOR ANTAGONISM IN THE RAT
Authors: PANAGIOTOPOULOS S BURRELL LM JERUMS G PHILLIPS PA RISVANIS J JOHNSTON CI
Citation: S. Panagiotopoulos et al., IN-VIVO EFFECT OF CHRONIC VASOPRESSIN V1 AND V2 RECEPTOR ANTAGONISM IN THE RAT, Journal of the American Society of Nephrology, 6(3), 1995, pp. 327-327
ATTENUATION OF GENETIC-HYPERTENSION AFTER SHORT-TERM VASOPRESSIN V1A RECEPTOR ANTAGONISM
Authors: BURRELL LM PHILLIPS PA RISVANIS J ALDRED KL HUTCHINS AM JOHNSTON CI
Citation: Lm. Burrell et al., ATTENUATION OF GENETIC-HYPERTENSION AFTER SHORT-TERM VASOPRESSIN V1A RECEPTOR ANTAGONISM, Hypertension, 26(5), 1995, pp. 828-834
DIFFERENTIAL-EFFECTS OF A NOVEL NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) IN RAT-LIVER AND VASCULATURE
Authors: PHILLIPS PA RISVANIS J ALDRED K BURRELL LM BARTHOLOMEUSZ B
Citation: Pa. Phillips et al., DIFFERENTIAL-EFFECTS OF A NOVEL NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) IN RAT-LIVER AND VASCULATURE, Clinical science, 89(6), 1995, pp. 575-579
DOWN-REGULATION OF VASOPRESSIN V1A RECEPTOR MESSENGER-RNA IN DIABETES-MELLITUS IN THE RAT
Authors: PHILLIPS PA RISVANIS J HUTCHINS AM BURRELL LM MACGREGOR D GUNDLACH AL JOHNSTON CI
Citation: Pa. Phillips et al., DOWN-REGULATION OF VASOPRESSIN V1A RECEPTOR MESSENGER-RNA IN DIABETES-MELLITUS IN THE RAT, Clinical science, 88(6), 1995, pp. 671-674
ANDROGEN MANIPULATION AND VASOPRESSIN BINDING IN THE RAT-BRAIN AND PERIPHERAL ORGANS
Authors: GAO X PHILLIPS P OLDFIELD B TRINDER D RISVANIS J STEPHENSON J JOHNSTON C
Citation: X. Gao et al., ANDROGEN MANIPULATION AND VASOPRESSIN BINDING IN THE RAT-BRAIN AND PERIPHERAL ORGANS, European journal of endocrinology, 130(3), 1994, pp. 291-296
EFFECTS OF ANTIEMETICS ON WATER-EXCRETION IN HUMANS
Authors: PHILLIPS PA BURRELL LM RISVANIS J STEPHENSON J JOHNSTON CI HUTCHINS AM
Citation: Pa. Phillips et al., EFFECTS OF ANTIEMETICS ON WATER-EXCRETION IN HUMANS, Clinical and experimental pharmacology and physiology, 21(1), 1994, pp. 59-62
BLOOD-PRESSURE-LOWERING EFFECT OF AN ORALLY-ACTIVE VASOPRESSIN V(1) RECEPTOR ANTAGONIST IN MINERALOCORTICOID HYPERTENSION IN THE RAT
Authors: BURRELL LM PHILLIPS PA STEPHENSON JM RISVANIS J ROLLS KA JOHNSTON CI
Citation: Lm. Burrell et al., BLOOD-PRESSURE-LOWERING EFFECT OF AN ORALLY-ACTIVE VASOPRESSIN V(1) RECEPTOR ANTAGONIST IN MINERALOCORTICOID HYPERTENSION IN THE RAT, Hypertension, 23(6), 1994, pp. 737-743
EPIDERMAL GROWTH-FACTOR ANTAGONIZES VASOPRESSIN IN-VIVO AND IN-VITRO
Authors: PHILLIPS PA GRANT SL DAVIDSON AF RISVANIS J STEPHENSON J GOW CB
Citation: Pa. Phillips et al., EPIDERMAL GROWTH-FACTOR ANTAGONIZES VASOPRESSIN IN-VIVO AND IN-VITRO, Kidney international, 45(4), 1994, pp. 1028-1036
CHARACTERIZATION OF NONPEPTIDE ORALLY-ACTIVE AVP RECEPTOR ANTAGONISTS
Authors: BURRELL LM PHILLIPS PA RISVANIS J STEPHENSON J JOHNSTON CI
Citation: Lm. Burrell et al., CHARACTERIZATION OF NONPEPTIDE ORALLY-ACTIVE AVP RECEPTOR ANTAGONISTS, Kidney international, 45(4), 1994, pp. 1261-1261
REDUCED OROPHARYNGEAL INHIBITION OF AVP SECRETION IN THE ELDERLY
Authors: PHILLIPS PA RISVANIS J STEPHENSON J CASLEY D JOHNSTON CI GRAY L
Citation: Pa. Phillips et al., REDUCED OROPHARYNGEAL INHIBITION OF AVP SECRETION IN THE ELDERLY, Kidney international, 45(4), 1994, pp. 1261-1262
DIFFERENTIAL REGULATION OF V1 AND V2 VASOPRESSIN RECEPTORS IN DIABETES-MELLITUS
Authors: PHILLIPS PA TRINDER D STEPHENSON J RISVANIS J COOPER M JOHNSON CI
Citation: Pa. Phillips et al., DIFFERENTIAL REGULATION OF V1 AND V2 VASOPRESSIN RECEPTORS IN DIABETES-MELLITUS, Kidney international, 45(4), 1994, pp. 1275-1276
V-1-LIKE [ARG(8)]VASOPRESSIN BINDING-SITES OCCUR IN RAT HEPATOCYTE NUCLEI
Authors: PHILLIPS PA HUTCHINS AM BURRELL LM RISVANIS J JOHNSTON CI
Citation: Pa. Phillips et al., V-1-LIKE [ARG(8)]VASOPRESSIN BINDING-SITES OCCUR IN RAT HEPATOCYTE NUCLEI, European journal of pharmacology, 259(3), 1994, pp. 325-329
VASOPRESSIN V-1 AND V-2 RECEPTORS IN DIABETES-MELLITUS
Authors: TRINDER D PHILLIPS PA STEPHENSON JM RISVANIS J AMINIAN A ADAM W COOPER M JOHNSTON CI
Citation: D. Trinder et al., VASOPRESSIN V-1 AND V-2 RECEPTORS IN DIABETES-MELLITUS, The American journal of physiology, 266(2), 1994, pp. 50000217-50000223
EFFECTS OF AN ORALLY ACTIVE VASOPRESSIN V(1)-RECEPTOR ANTAGONIST
Authors: BURRELL LM PHILLIPS PA STEPHENSON J RISVANIS J HUTCHINS AM JOHNSTON CI
Citation: Lm. Burrell et al., EFFECTS OF AN ORALLY ACTIVE VASOPRESSIN V(1)-RECEPTOR ANTAGONIST, Clinical and experimental pharmacology and physiology, 20(5), 1993, pp. 388-391
CHARACTERIZATION OF A NOVEL NONPEPTIDE VASOPRESSIN V(1) RECEPTOR ANTAGONIST (OPC-21268) IN THE RAT
Authors: BURRELL LM PHILLIPS PA STEPHENSON J RISVANIS J HUTCHINS AM JOHNSTON CI
Citation: Lm. Burrell et al., CHARACTERIZATION OF A NOVEL NONPEPTIDE VASOPRESSIN V(1) RECEPTOR ANTAGONIST (OPC-21268) IN THE RAT, Journal of Endocrinology, 138(2), 1993, pp. 259-266
EFFECTS OF DRINKING ON THIRST AND VASOPRESSIN IN DEHYDRATED ELDERLY MEN
Authors: PHILLIPS PA BRETHERTON M RISVANIS J CASLEY D JOHNSTON C GRAY L
Citation: Pa. Phillips et al., EFFECTS OF DRINKING ON THIRST AND VASOPRESSIN IN DEHYDRATED ELDERLY MEN, The American journal of physiology, 264(5), 1993, pp. 877-881
Risultati: 1-25 |